Target intelligence / Profile preview

Wound Proteases

Molecular classification
Enzyme, Hydrolase, Protease, Matrix metalloproteinase, Serine protease
01

Overview

Wound environment proteases are a diverse group of enzymes, primarily consisting of matrix metalloproteinases (MMPs) and serine proteases like neutrophil elastase, that are essential for normal wound healing processes such as debridement and tissue remodeling [1][2]. In healthy tissue, these proteases are strictly regulated by endogenous inhibitors like tissue inhibitors of metalloproteinases (TIMPs); however, in chronic wounds, this balance is disrupted, leading to pathologically high levels of protease activity [2][3]. This excess causes the degradation of the extracellular matrix, growth factors, and their receptors, effectively stalling the wound in a persistent inflammatory state and preventing closure [3][4]. Therapeutic interventions, such as protease-modulating dressings (e.g., those containing collagen or sucrose octasulfate), aim to sequester or inhibit these enzymes to restore a favorable biochemical environment for healing [5][6]. Monitoring protease levels, particularly MMP-9 and elastase, serves as a valuable biomarker for assessing wound chronicity and the efficacy of treatment [1][7].

Other names
Wound environment proteasesChronic wound proteasesWound-associated proteasesMatrix metalloproteinases and serine proteases in wounds
02

Mechanism of action

Protease modulation through sequestration of enzymes within the dressing matrix, competitive inhibition of the catalytic site, or chelation of essential metal ions (e.g., zinc) required for enzyme activity, thereby restoring the balance between tissue degradation and synthesis.

03

Biological functions

Extracellular matrix remodelingInflammationTissue repairCell migrationDebridementGrowth factor regulation
04

Disease associations

Chronic woundDiabetic foot ulcerVenous leg ulcerPressure ulcerImpaired wound healing
05

Safety considerations

Impaired healing due to excessive protease inhibitionLocal skin irritation or hypersensitivity to dressing componentsRisk of secondary infection if wound bed is not properly monitoredPotential systemic effects with non-selective small molecule inhibitors
06

Interacting drugs

Collagen/Oxidized Regenerated Cellulose (Promogran)

6 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Neutrophil elastase (NE)Matrix metalloproteinase-2 (MMP-2)MMP/TIMP ratioWound fluid pH

Beyond the preview

Go deeper on Wound Proteases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wound Proteases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call